BUZZ-Saluda Medical slumps nearly 50% in bruising ASX debut
Reuters
Dec 05, 2025
BUZZ-Saluda Medical slumps nearly 50% in bruising ASX debut
** Australian-listed shares of Saluda Medical SLD.AX sinks as much as 46.98% to A$1.405 in bruising ASX debut
** U.S.-based medtech firm raises A$231 million ($152.67 million) in ASX listing
** Co sold 87.1 mln new CHESS Depositary Interests at A$2.65 each, pegging market value near A$775 mln at listing
** Founded in Sydney in 2010, SLD developed FDA-cleared Evoke spinal cord stimulation, a closed-loop platform that measures and adapts therapy in real time using neural biomarkers
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.